Results 71 to 80 of about 87,373,768 (197)

The Concurrent Initiation of Medications Is Associated with Discontinuation of Buprenorphine Treatment for Opioid Use Disorder

, 2020
Introduction Retention in buprenorphine treatment for opioid use disorder (OUD) yields better opioid abstinence and reduces all-cause mortality for patients with OUD.
Chiang, Chien-Wei, Cheng, Feixiong, Donneyong, Macarius, Huang, Lei Frank, Quinney, Sara, Zhang, Pengyue, Lu, Bo   +6 more
core   +1 more source

Targeting the Orexin System for Prescription Opioid Use Disorder

, 2020
Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to
Rémi Martin-Fardon, Alessandra Matzeu
core   +1 more source

Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder

Addiction Science & Clinical Practice, 2020
Background Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time following medication induction in which
Kirsten J. Langdon, Susan Ramsey, Caroline Scherzer, Kate Carey, Megan L. Ranney, Josiah Rich   +5 more
doaj   +1 more source

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery

Annals of Surgery Open
Objective: We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events.
Li, Alicia H., Huang, Yongmei, Martins, Silvia S., Suzuki, Yukio, Ferris, Jennifer S., Xu, Xiao, Hershman, Dawn L., Wright, Jason D.   +7 more
openaire   +2 more sources

Integrating opioid use disorder treatment into primary care settings.

, 2023
Importance: Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist.
Heald, Ashley, Ratzliff, Anna D, Williams, Emily C, Saxon, Andrew J, Chen, Jessica, Merrill, Joseph O, Austin, Elizabeth J, Briggs, Elsa S, Curran, Geoffrey M, Ferro, Lori, Fortney, John C, Barry, Paul   +11 more
core   +1 more source

Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives

Addiction Science & Clinical Practice
Background Implementation of medications for opioid use disorder (MOUD) in jails varies by facility and across states. Organizational climate, including staff attitudes toward change and exposure to education, can influence perceptions of innovations ...
Pryce S. Michener, Elizabeth A. Evans, Warren J. Ferguson, Peter D. Friedmann   +3 more
doaj   +1 more source

Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder

Substance Abuse Treatment, Prevention, and Policy
Background The opioid epidemic contributes to increasing morbidity and mortality due to drug overdoses in the US, but barriers to traditional opioid use disorder (OUD) treatment prevent a vast majority of patients from accessing quality care and ...
Laura B. Monico, Megan Eastlick, Darcy Michero, Peyton Pielsticker, Suzette Glasner   +4 more
doaj   +1 more source

Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice
Background Hospitalizations involving opioid use disorder (OUD) are increasing. Addiction consultation services (ACS) initiate medications for opioid use disorder (MOUD) in hospital settings and arrange post-hospital follow-up for ongoing MOUD care ...
Gavin Bart, Kelly S. Barth, Paulette Baukol, Eva Enns, Udi E. Ghitza, Jacklyn Harris, Eve Jelstrom, Jane M. Liebschutz, Kara M. Magane, Delia Voronca, Zoe M. Weinstein, P. Todd Korthuis   +11 more
doaj   +1 more source

Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder

Addiction Science & Clinical Practice
Background Hospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization.
Gavin Bart, P. Todd Korthuis, Julie M. Donohue, Hildi J. Hagedorn, Dave H. Gustafson, Angela R. Bazzi, Eva Enns, Jennifer McNeely, Udi E. Ghitza, Kara M. Magane, Paulette Baukol, Ashley Vena, Jacklyn Harris, Delia Voronca, Richard Saitz   +14 more
doaj   +1 more source

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study

Rural and Remote Health
Introduction: Rates of N-methylamphetamine (methamphetamine) use in rural areas of the US have been steadily increasing, particularly among individuals who are already struggling with opioid use disorder.
Leslie Kenefick, Lisa Khairy, Luke Hall, Kibeom Kwon, Nicole Limberg, Kirsi Kirk-Lewis, Megan Lewis, Matt Owen, Sterling McPherson, Andre Miguel   +9 more
doaj   +1 more source